BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8878246)

  • 1. Influence of biochemical parameters of liver function on vancomycin pharmacokinetics.
    Martí R; Rosell M; Pou L; García L; Pascual C
    Pharmacol Toxicol; 1996 Aug; 79(2):55-9. PubMed ID: 8878246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of vancomycin pharmacokinetics in hospitalized elderly and young patients using a Bayesian forecaster.
    Guay DR; Vance-Bryan K; Gilliland S; Rodvold K; Rotschafer J
    J Clin Pharmacol; 1993 Oct; 33(10):918-22. PubMed ID: 8227461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in vancomycin pharmacokinetics during treatment.
    Pou L; Rosell M; Lopez R; Pascual C
    Ther Drug Monit; 1996 Apr; 18(2):149-53. PubMed ID: 8721277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin serum concentrations in patients with renal dysfunction: a comparison of fluorescence polarization immunoassay and the enzyme-multiplied immunoassay technique.
    Peckman HJ; Dupuis RE; Sawyer WT; Brouwer KL; Cross RE
    Ther Drug Monit; 1996 Dec; 18(6):647-53. PubMed ID: 8946660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes of liver enzymes during severe infections].
    Conde Martel A; Santolaria Fernández F; González Reimers E; Batista López N; Gómez Sirvent JL; Essardas H; Martínez Riera A; Rodríguez Hernández A
    Rev Esp Enferm Apar Dig; 1989 Jun; 75(6 Pt 2):651-5. PubMed ID: 2570447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between elevated serum hepatic enzyme activity and total body fat in obese humans.
    Choi JW
    Ann Clin Lab Sci; 2003; 33(3):257-64. PubMed ID: 12956439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hepatic function on vancomycin pharmacokinetics in patients with cancer.
    Aldaz A; Ortega A; Idoate A; Giráldez J; Brugarolas A
    Ther Drug Monit; 2000 Jun; 22(3):250-7. PubMed ID: 10850390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin monitoring: one or two serum levels?
    Andrés I; López R; Pou L; Piñol F; Pascual C
    Ther Drug Monit; 1997 Dec; 19(6):614-9. PubMed ID: 9421100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A young woman, 25 weeks pregnant, in labor with fever and abnormal serum liver enzymes.
    Grier JF; Gholson CF; Fowler M; Abreo K
    J La State Med Soc; 1994 Mar; 146(3):83-8. PubMed ID: 7964115
    [No Abstract]   [Full Text] [Related]  

  • 10. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
    Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
    Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.
    Vance-Bryan K; Guay DR; Gilliland SS; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 1993 Mar; 37(3):436-40. PubMed ID: 8460912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of fluoride therapy on blood chemistry parameters in osteoporotic females.
    Jackson R; Kelly S; Noblitt T; Zhang W; Dunipace A; Li Y; Stookey G; Katz B; Brizendine E; Farley S
    Bone Miner; 1994 Oct; 27(1):13-23. PubMed ID: 7849542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin Pharmacokinetics in Patients with Advanced Cancer Near End of Life.
    Nakayama H; Suzuki M; Kato T; Echizen H
    Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):837-843. PubMed ID: 31154618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of vancomycin in patients with severely impaired renal function.
    Gonzalez-Martin G; Acuna V; Perez C; Labarca J; Guevara A; Tagle R
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):71-5. PubMed ID: 8929749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.
    Radke C; Horn D; Lanckohr C; Ellger B; Meyer M; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Jul; 56(7):759-779. PubMed ID: 28039606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
    Pea F; Porreca L; Baraldo M; Furlanut M
    J Antimicrob Chemother; 2000 Mar; 45(3):329-35. PubMed ID: 10702552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of vancomycin in patients with severe acute pancreatitis.
    He J; Mao EQ; Feng J; Jiang HT; Yang WH; Chen EZ
    Eur J Clin Pharmacol; 2016 Jun; 72(6):697-702. PubMed ID: 26902230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of vancomycin pharmacokinetics during cardiopulmonary bypass in patients undergoing cardiac surgery.
    Ortega GM; Martí-Bonmatí E; Guevara SJ; Gómez IG
    Am J Health Syst Pharm; 2003 Feb; 60(3):260-5. PubMed ID: 12613235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough Levels.
    Haeseker M; Croes S; Neef C; Bruggeman C; Stolk L; Verbon A
    Ther Drug Monit; 2016 Feb; 38(1):120-6. PubMed ID: 26418699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.